Bruno Sangro

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 39

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Cancers

Cardiovascular and interventional radiology

Clinical cancer research : an official journal of the American Association for Cancer Research

Clinica Universidad de Navarra

Universidad de Navarra (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Clinica Universidad de Navarra Oct 01 2016

Spain

Director :: Liver Unit

Universidad de Navarra Sep 01 2016

Spain

Professor :: Internal Medicine

Education History

Universidad de Navarra

Spain

PHD

Publications

Bruno Sangro, Peter R Galle, Robin Kate Kelley, Chaiyut Charoentum, Enrico N De Toni, Yurii Ostapenko, Jeong Heo, Ann-Lii Cheng, Andrea Wilson Woods, Charu Gupta, Jayne Abraham, Carrie L McCoy, Nikunj Patel, Alejandra Negro, Arndt Vogel, Ghassan K Abou-Alfa
Patient-Reported Outcomes From the Phase III HIMALAYA Study of Tremelimumab Plus Durvalumab in Unresectable Hepatocellular Carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (23) (2024)
Bruno Sangro, Peter R Galle, Robin Kate Kelley, Chaiyut Charoentum, Enrico N De Toni, Yurii Ostapenko, Jeong Heo, Ann-Lii Cheng, Andrea Wilson Woods, Charu Gupta, Jayne Abraham, Carrie L McCoy, Nikunj Patel, Alejandra Negro, Arndt Vogel, Ghassan K Abou-Alfa
Patient-Reported Outcomes From the Phase III HIMALAYA Study of Tremelimumab Plus Durvalumab in Unresectable Hepatocellular Carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (23) (2024)
Sergio Barace, Eva Santamaría, Stefany Fiorella Infante Varillas, Sara Arcelus, Jesus De La Fuente, Enrique Goñi, Ibon Tamayo, Idoia Ochoa, Miguel Sogbe, Bruno Sangro, Mikel Hernaez, Matias A Avila, Josepmaria Argemi
Application of Graph Models to the Identification of Transcriptomic Oncometabolic Pathways in Human Hepatocellular Carcinoma. Biomolecules 14 (6) (2024)
Sergio Barace, Eva Santamaría, Stefany Fiorella Infante Varillas, Sara Arcelus, Jesus De La Fuente, Enrique Goñi, Ibon Tamayo, Idoia Ochoa, Miguel Sogbe, Bruno Sangro, Mikel Hernaez, Matias A Avila, Josepmaria Argemi
Application of Graph Models to the Identification of Transcriptomic Oncometabolic Pathways in Human Hepatocellular Carcinoma. Biomolecules 14 (6) (2024)
Bruno Sangro, Peter R Galle, Robin Kate Kelley, Chaiyut Charoentum, Enrico N De Toni, Yurii Ostapenko, Jeong Heo, Ann-Lii Cheng, Andrea Wilson Woods, Charu Gupta, Jayne Abraham, Carrie L McCoy, Nikunj Patel, Alejandra Negro, Arndt Vogel, Ghassan K Abou-Alfa
Patient-Reported Outcomes From the Phase III HIMALAYA Study of Tremelimumab Plus Durvalumab in Unresectable Hepatocellular Carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Bruno Sangro, Peter R Galle, Robin Kate Kelley, Chaiyut Charoentum, Enrico N De Toni, Yurii Ostapenko, Jeong Heo, Ann-Lii Cheng, Andrea Wilson Woods, Charu Gupta, Jayne Abraham, Carrie L McCoy, Nikunj Patel, Alejandra Negro, Arndt Vogel, Ghassan K Abou-Alfa
Patient-Reported Outcomes From the Phase III HIMALAYA Study of Tremelimumab Plus Durvalumab in Unresectable Hepatocellular Carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (23) (2024)
Bruno Sangro, Thomas Yau, Anthony B El-Khoueiry, Masatoshi Kudo, Yun Shen, Marina Tschaika, Amit Roy, Yan Feng, Ling Gao, Urvi Aras
Exposure-response analysis for nivolumab plus ipilimumab combination therapy in patients with advanced hepatocellular carcinoma (CheckMate 040). Clinical and translational science (2023)
Daniel Aliseda, Pablo Martí-Cruchaga, Gabriel Zozaya, Macarena Rodríguez-Fraile, José I Bilbao, Alberto Benito-Boillos, Antonio Martínez De La Cuesta, Luis Lopez-Olaondo, Francisco Hidalgo, Mariano Ponz-Sarvisé, Ana Chopitea, Javier Rodríguez Rodríguez, Mercedes Iñarrairaegui, Jose Ignacio Herrero, Fernando Pardo, Bruno Sangro, Fernando Rotellar
Liver Resection and Transplantation Following Yttrium-90 Radioembolization for Primary Malignant Liver Tumors: A 15-Year Single-Center Experience. Cancers 15 (3) (2023)
José María Herranz, Amaya López-Pascual, Alex Clavería-Cabello, Iker Uriarte, Maria U Latasa, Ainara Irigaray-Miramon, Elena Adán-Villaescusa, Borja Castelló-Uribe, Bruno Sangro, María Arechederra, Carmen Berasain, Matias A Avila, Maite G Férnandez-Barrena
Comprehensive analysis of epigenetic and epitranscriptomic genes' expression in human NAFLD. Journal of physiology and biochemistry (2023)
Paloma Sangro, Manuel de la Torre-Aláez, Bruno Sangro, Delia D'Avola
Metabolic dysfunction-associated fatty liver disease (MAFLD): an update of the recent advances in pharmacological treatment. Journal of physiology and biochemistry (2023)
Daniel Aliseda, Pablo Martí-Cruchaga, Gabriel Zozaya, Macarena Rodríguez-Fraile, José I Bilbao, Alberto Benito-Boillos, Antonio Martínez De La Cuesta, Luis Lopez-Olaondo, Francisco Hidalgo, Mariano Ponz-Sarvisé, Ana Chopitea, Javier Rodríguez Rodríguez, Mercedes Iñarrairaegui, Jose Ignacio Herrero, Fernando Pardo, Bruno Sangro, Fernando Rotellar
Liver Resection and Transplantation Following Yttrium-90 Radioembolization for Primary Malignant Liver Tumors: A 15-Year Single-Center Experience. Cancers 15 (3) (2023)
Jorge Aramburu, Raúl Antón, Bruno Sangro
How Could 90 Y-Loaded Microsphere Distribution Be Optimized? Cardiovascular and interventional radiology 45 (7) (2022)
Thomas Yau, Vittorina Zagonel, Armando Santoro, Mirelis Acosta-Rivera, Su Pin Choo, Ana María Matilla, Aiwu Ruth He, Antonio Cubillo Gracian, Anthony B El-Khoueiry, Bruno Sangro, Tarek E Eldawy, Jordi Bruix, Giovanni Luca Frassineti, Gina M Vaccaro, Marina Tschaika, Christian Scheffold, Petra Koopmans, Jaclyn Neely, Fabio Piscaglia
Nivolumab Plus Cabozantinib With or Without Ipilimumab for Advanced Hepatocellular Carcinoma: Results From Cohort 6 of the CheckMate 040 Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 41 (9) (2022)
Bruno Sangro, Josepmaria Argemi
Immunotherapy in HCC-No rush despite the hype. Hepatology (Baltimore, Md.) 76 (4) (2022)
Andrew X Zhu, Farshid Dayyani, Chia-Jui Yen, Zhenggang Ren, Yuxian Bai, Zhiqiang Meng, Hongming Pan, Paul Dillon, Shivani K Mhatre, Vincent E Gaillard, Sairy Hernandez, Robin Kate Kelley, Bruno Sangro
Alpha-Fetoprotein as a Potential Surrogate Biomarker for Atezolizumab + Bevacizumab Treatment of Hepatocellular Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (16) (2022)
Thomas Yau, Vittorina Zagonel, Armando Santoro, Mirelis Acosta-Rivera, Su Pin Choo, Ana María Matilla, Aiwu Ruth He, Antonio Cubillo Gracian, Anthony B El-Khoueiry, Bruno Sangro, Tarek E Eldawy, Jordi Bruix, Giovanni Luca Frassineti, Gina M Vaccaro, Marina Tschaika, Christian Scheffold, Petra Koopmans, Jaclyn Neely, Fabio Piscaglia
Nivolumab Plus Cabozantinib With or Without Ipilimumab for Advanced Hepatocellular Carcinoma: Results From Cohort 6 of the CheckMate 040 Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 41 (9) (2022)
Miriam Recalde, María Gárate-Rascón, José María Herranz, María Elizalde, María Azkona, Juan Pablo Unfried, Loreto Boix, Maria Reig, Bruno Sangro, Maite G Férnandez-Barrena, Puri Fortes, Matias A Avila, Carmen Berasain, María Arechederra
DNA Methylation Regulates a Set of Long Non-Coding RNAs Compromising Hepatic Identity during Hepatocarcinogenesis. Cancers 14 (9) (2022)
Thomas Yau, Vittorina Zagonel, Armando Santoro, Mirelis Acosta-Rivera, Su Pin Choo, Ana María Matilla, Aiwu Ruth He, Antonio Cubillo Gracian, Anthony B El-Khoueiry, Bruno Sangro, Tarek E Eldawy, Jordi Bruix, Giovanni Luca Frassineti, Gina M Vaccaro, Marina Tschaika, Christian Scheffold, Petra Koopmans, Jaclyn Neely, Fabio Piscaglia
Nivolumab Plus Cabozantinib With or Without Ipilimumab for Advanced Hepatocellular Carcinoma: Results From Cohort 6 of the CheckMate 040 Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Thomas Yau, Vittorina Zagonel, Armando Santoro, Mirelis Acosta-Rivera, Su Pin Choo, Ana María Matilla, Aiwu Ruth He, Antonio Cubillo Gracian, Anthony B El-Khoueiry, Bruno Sangro, Tarek E Eldawy, Jordi Bruix, Giovanni Luca Frassineti, Gina M Vaccaro, Marina Tschaika, Christian Scheffold, Petra Koopmans, Jaclyn Neely, Fabio Piscaglia
Nivolumab Plus Cabozantinib With or Without Ipilimumab for Advanced Hepatocellular Carcinoma: Results From Cohort 6 of the CheckMate 040 Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 41 (9) (2022)
Timothy Wai Ho Shuen, Marianna Alunni-Fabbroni, Elif Öcal, Peter Malfertheiner, Moritz Wildgruber, Regina Schinner, Maciej Pech, Julia Benckert, Bruno Sangro, Christiane K Kuhl, Antonio Gasbarrini, Pierce Kah-Hoe Chow, Han Chong Toh, Jens Ricke
Extracellular Vesicles May Predict Response to Radioembolization and Sorafenib Treatment in Advanced Hepatocellular Carcinoma: An Exploratory Analysis from the SORAMIC Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (17) (2022)
Julio Ortega, Raúl Antón, Juan Carlos Ramos González, Alejandro Rivas, Gorka S Larraona, Bruno Sangro, José Ignacio Bilbao, Jorge Aramburu
Computational study of a novel catheter for liver radioembolization. International journal for numerical methods in biomedical engineering 38 (4) (2022)
Ángela Martínez Herreros, Bruno Sangro, Alba García Rodriguez, Virginia Pérez Grijalba
Analysis of the albumin-bilirubin score as an indicator of improved liver function among hepatitis C virus patients with sustained viral response after direct-acting antiviral therapy. JGH open : an open access journal of gastroenterology and hepatology 6 (7) (2022)
Thomas Yau, Vittorina Zagonel, Armando Santoro, Mirelis Acosta-Rivera, Su Pin Choo, Ana María Matilla, Aiwu Ruth He, Antonio Cubillo Gracian, Anthony B El-Khoueiry, Bruno Sangro, Tarek E Eldawy, Jordi Bruix, Giovanni Luca Frassineti, Gina M Vaccaro, Marina Tschaika, Christian Scheffold, Petra Koopmans, Jaclyn Neely, Fabio Piscaglia
Nivolumab Plus Cabozantinib With or Without Ipilimumab for Advanced Hepatocellular Carcinoma: Results From Cohort 6 of the CheckMate 040 Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Markus W Löffler, Stefania Gori, Francesco Izzo, Andrea Mayer-Mokler, Paolo Antonio Ascierto, Alfred Königsrainer, Yuk Ting Ma, Bruno Sangro, Sven Francque, Luisa Vonghia, Alessandro Inno, Antonio Avallone, Jörg Ludwig, Diego Duarte Alcoba, Christian Flohr, Katrin Aslan, Regina Mendrzyk, Heiko Schuster, Marco Borrelli, Danila Valmori, Tanguy Chaumette, Regina Heidenreich, Cécile Gouttefangeas, Greta Forlani, Maria Tagliamonte, Caterina Fusco, Roberta Penta, Mercedes Iñarrairaegui, Ulrike Gnad-Vogt, Carsten Reinhardt, Toni Weinschenk, Roberto Sergio Accolla, Harpreet Singh-Jasuja, Hans-Georg Rammensee, Luigi Buonaguro
Phase I/II Multicenter Trial of a Novel Therapeutic Cancer Vaccine, HepaVac-101, for Hepatocellular Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (12) (2022)
Thomas Yau, Vittorina Zagonel, Armando Santoro, Mirelis Acosta-Rivera, Su Pin Choo, Ana María Matilla, Aiwu Ruth He, Antonio Cubillo Gracian, Anthony B El-Khoueiry, Bruno Sangro, Tarek E Eldawy, Jordi Bruix, Giovanni Luca Frassineti, Gina M Vaccaro, Marina Tschaika, Christian Scheffold, Petra Koopmans, Jaclyn Neely, Fabio Piscaglia
Nivolumab Plus Cabozantinib With or Without Ipilimumab for Advanced Hepatocellular Carcinoma: Results From Cohort 6 of the CheckMate 040 Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 41 (9) (2022)
Marina Barriocanal, Celia Prior, Beatriz Suarez, Juan Pablo Unfried, Nerea Razquin, Sandra Hervás-Stubbs, Bruno Sangro, Victor Segura, Puri Fortes
Long Noncoding RNA EGOT Responds to Stress Signals to Regulate Cell Inflammation and Growth. Journal of immunology (Baltimore, Md. : 1950) 206 (8) (2021)
Jorge Aramburu, Raúl Antón, Macarena Rodriguez-Fraile, Bruno Sangro, José Ignacio Bilbao
Computational Fluid Dynamics Modeling of Liver Radioembolization: A Review. Cardiovascular and interventional radiology (2021)
Jorge Aramburu, Raúl Antón, Junichi Fukamizu, Daiki Nozawa, Makoto Takahashi, Kouji Ozaki, Juan Carlos Ramos González, Bruno Sangro, José Ignacio Bilbao, Kosuke Tomita, Tomohiro Matsumoto, Terumitsu Hasebe
In Vitro Model for Simulating Drug Delivery during Balloon-Occluded Transarterial Chemoembolization. Biology 10 (12) (2021)
Fabiana Grisanti, Elena Prieto, Juan Fernando Bastidas, Lidia Sancho Rodríguez, Pablo Rodrigo, Carmen Beorlegui, Mercedes Iñarrairaegui, José Ignacio Bilbao, Bruno Sangro, Macarena Rodriguez-Fraile
3D voxel-based dosimetry to predict contralateral hypertrophy and an adequate future liver remnant after lobar radioembolization. European journal of nuclear medicine and molecular imaging 48 (10) (2021)
Hugo Levillain, Oreste Bagni, Christophe M Deroose, Arnaud Dieudonné, Silvano Gnesin, Oliver S Grosser, Srinivasan Cheenu Kappadath, Andrew S Kennedy, Nima Kokabi, David M Liu, David C Madoff, Armeen Mahvash, Antonio Martinez de la Cuesta, David C E Ng, Philipp M Paprottka, Cinzia Pettinato, Macarena Rodriguez-Fraile, Riad Salem, Bruno Sangro, Lidia Strigari, Daniel Y Sze, Berlinda Jantina de Wit-van der Veen, Patrick Flamen
International recommendations for personalised selective internal radiation therapy of primary and metastatic liver diseases with yttrium-90 resin microspheres. European journal of nuclear medicine and molecular imaging 48 (5) (2021)
Mercedes Iñarrairaegui, Bruno Sangro
Selective Internal Radiation Therapy Approval for Early HCC: What Comes Next? Hepatology (Baltimore, Md.) 74 (5) (2021)
Bruno Sangro, Pablo Sarobe, Sandra Hervás-Stubbs, Ignacio Melero Bermejo
Advances in immunotherapy for hepatocellular carcinoma. Nature reviews. Gastroenterology & hepatology 18 (8) (2021)
Juan Pablo Unfried, Paloma Sangro, Laura Prats-Mari, Bruno Sangro, Puri Fortes
The Landscape of lncRNAs in Hepatocellular Carcinoma: A Translational Perspective. Cancers 13 (11) (2021)
Juan Pablo Unfried, Mikel Marín-Baquero, Angel Rivera-Calzada, Nerea Razquin, Eva M Martín-Cuevas, Sara de Bragança, Clara Aicart-Ramos, Christopher McCoy, Laura Prats-Mari, Raquel Arribas-Bosacoma, Linda Lee, Stefano Caruso, Jessica Zucman-Rossi, Bruno Sangro, Gareth Williams, Fernando Moreno-Herrero, Oscar Llorca, Susan P Lees-Miller, Puri Fortes
Long Noncoding RNA NIHCOLE Promotes Ligation Efficiency of DNA Double-Strand Breaks in Hepatocellular Carcinoma. Cancer research 81 (19) (2021)
Thomas Helmberger, Dirk Arnold, José Ignacio Bilbao, Niels de Jong, Geert Maleux, Anders Nordlund, Bora Peynircioglu, Bruno Sangro, Ricky A Sharma, Agnes Walk
Clinical Application of Radioembolization in Hepatic Malignancies: Protocol for a Prospective Multicenter Observational Study. JMIR research protocols 9 (4) (2020)
Julio Ortega, Raúl Antón, Juan Carlos Ramos González, Alejandro Rivas, Gorka S Larraona, Bruno Sangro, José Ignacio Bilbao, Jorge Aramburu
On the importance of spiral-flow inflow boundary conditions when using idealized artery geometries in the analysis of liver radioembolization: A parametric study. International journal for numerical methods in biomedical engineering 36 (6) (2020)
Delia D'Avola, Jose I Bilbao, Bruno Sangro
Hepatocellular Carcinoma: Essentials Interventional Radiologists Need to Know. Cardiovascular and interventional radiology 42 (9) (2019)
Juan P Unfried, Guillermo Serrano, Beatriz Suárez, Paloma Sangro, Valeria Ferretti, Celia Prior, Loreto Boix, Jordi Bruix, Bruno Sangro, Víctor Segura, Puri Fortes
Identification of Coding and Long Noncoding RNAs Differentially Expressed in Tumors and Preferentially Expressed in Healthy Tissues. Cancer research 79 (20) (2019)
Diana Llopiz, Marta Ruiz, Lorea Villanueva, Tamara Iglesias, Leyre Silva, Josune Egea, Juan Jose Lasarte, Perrine Pivette, Véronique Trochon-Joseph, Bérangère Vasseur, Graham Dixon, Bruno Sangro, Pablo Sarobe
Enhanced anti-tumor efficacy of checkpoint inhibitors in combination with the histone deacetylase inhibitor Belinostat in a murine hepatocellular carcinoma model. Cancer immunology, immunotherapy : CII 68 (3) (2018)

Bruno Sangro.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Bruno Sangro